. . . . . . . "[Here we use mass spectrometry to detect most dystrophin exons, and we express and physically characterize dystrophin 'nano'-constructs based on multiexon deletions that might find use in a large percentage of DMD patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:12:02+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .